tadalafil has been researched along with Acute Bacterial Prostatitis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 7 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulmonem, M; Abo-Elenen, M; Aboufarha, MO; Elgamal, SA; Radwan, MH; Tawfik, AM | 1 |
| Bai, Y; Dong, Z; Lao, Y; Wang, Y | 1 |
| Hiramatsu, I; Honda, S; Horie, S; Ishikawa, K; Iwata, S; Mitsuhashi, I; Mizuno, T; Nagashima, Y; Noto, K; Nozaki, T; Ogishima, T; Shigeta, Y; Shirai, M; Soejima, M; Sugimura, S; Takasu, J; Tsujimura, A; Uesaka, Y; Yoshiyama, A | 1 |
| Amano, T | 1 |
| Tanaka, T | 1 |
| Hayashida, Y; Hirama, H; Kekehi, Y; Matsuoka, Y; Miyauchi, Y; Naito, H; Osaki, Y; Sugimoto, M; Taoka, R; Tsunemori, H; Ueda, N; Zhang, X | 1 |
| Asao, Y; Kurita, M; Oka, M; Yamaguchi, H; Yoshinaga, R | 1 |
| Fujita, T; Funahashi, Y; Gotoh, M; Ishida, S; Kato, M; Matsukawa, Y; Naito, Y; Tochigi, K | 1 |
| Chen, G; Deng, Y; Li, C; Song, X; Yang, C | 1 |
| Kurita, M; Numakura, Y; Oka, M; Okamoto, K; Yamaguchi, H | 1 |
| Kotera, T; Kurita, M; Oka, M; Okamoto, K; Yamaguchi, H | 2 |
| Carson, C; Dasgupta, P; Kirby, RS | 1 |
| Grimsley, SJ; Jones, GE; Khan, MH | 1 |
2 review(s) available for tadalafil and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
[Experimental rodent models of chronic prostatitis: effect of phosphodiesterase 5 inhibitor on chronic pelvic-pain-related behavior].
Topics: Animals; Chronic Pain; Disease Models, Animal; Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Rodentia; Tadalafil | 2019 |
Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia?
Topics: Carbolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Phosphodiesterase 5 Inhibitors; Prostatitis; Tadalafil; Treatment Outcome | 2014 |
2 trial(s) available for tadalafil and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial.
Topics: Chronic Disease; Chronic Pain; Humans; Male; Middle Aged; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Tadalafil | 2022 |
Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Drug Resistance; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pelvic Pain; Plant Extracts; Pollen; Prospective Studies; Prostatitis; Tadalafil; Treatment Outcome; Urodynamics | 2020 |
10 other study(ies) available for tadalafil and Acute Bacterial Prostatitis
| Article | Year |
|---|---|
Comment on "Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double‑blind placebo controlled clinical trial".
Topics: Double-Blind Method; Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Tadalafil | 2022 |
Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
Topics: Adult; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatitis; Retrospective Studies; Severity of Illness Index; Tadalafil | 2020 |
Editorial Comment from Dr Amano to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
Topics: Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatitis; Tadalafil | 2020 |
Editorial Comment from Dr Tanaka to Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.
Topics: Humans; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Prostatitis; Tadalafil | 2020 |
A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis.
Topics: Animals; Disease Models, Animal; Male; Phosphodiesterase 5 Inhibitors; Prostate; Prostatitis; Rats; Rats, Wistar; Tadalafil | 2019 |
Tadalafil Alleviates LPS-Induced Inflammation and Oxidative Stress of RWPE-1 Cell by Regulating the Akt/Nrf2 Signaling Pathway.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Cell Proliferation; Cytokines; Humans; Inflammation Mediators; Lipopolysaccharides; Male; NF-E2-Related Factor 2; Oxidative Stress; Prostate; Prostatitis; Proto-Oncogene Proteins c-akt; Signal Transduction; Tadalafil | 2021 |
Effect of tadalafil on chronic pelvic pain and prostatic inflammation in a rat model of experimental autoimmune prostatitis.
Topics: Animals; Autoimmune Diseases; Chronic Pain; Disease Models, Animal; Humans; Male; Pelvic Pain; Prostate; Prostatitis; Rats; Rats, Wistar; Tadalafil; Urological Agents | 2018 |
Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: Effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain.
Topics: Analgesics; Animals; Autoimmune Diseases; Celecoxib; Chemokines; Chronic Pain; Cytokines; Disease Models, Animal; Immunoglobulin G; Male; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Pregabalin; Prostatitis; Rats; Rats, Wistar; RNA, Messenger; Tadalafil | 2018 |
Voiding behavior and chronic pelvic pain in two types of rat nonbacterial prostatitis models: Attenuation of chronic pelvic pain by repeated administration of tadalafil.
Topics: Animals; Autoimmune Diseases; Chronic Pain; Disease Models, Animal; Male; Orchiectomy; Pelvic Pain; Phosphodiesterase 5 Inhibitors; Prostatitis; Rats; Rats, Wistar; Tadalafil; Urination | 2019 |
Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Imidazoles; Immunity, Innate; Male; Models, Immunological; Nitric Oxide; Phosphodiesterase Inhibitors; Piperazines; Prostate; Prostatitis; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2007 |